Levetiracetam Krka

Levetiracetam, the active ingredient in Levetiracetam Krka, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of various seizure types in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the central nervous system.

- Partial onset seizures: helps control focal seizures that start in one area of the brain. - Generalized tonic‑clonic seizures: reduces the frequency and severity of convulsive seizures affecting the whole brain. - Myoclonic seizures: diminishes sudden, brief muscle jerks characteristic of myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate head pain. - Irritability: mood changes or agitation. - Nausea: occasional stomach upset. - Fatigue: reduced energy levels.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Depression or suicidal thoughts: mood disturbances requiring immediate attention. - Severe allergic reactions: including anaphylaxis. - Blood disorders: rare cases of leukopenia or thrombocytopenia. - Respiratory depression: uncommon but potentially life‑threatening breathing difficulty.

Before initiating levetiracetam therapy, several safety considerations should be addressed.

- Renal impairment: dose may need adjustment based on kidney function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare provider. - Concomitant CNS depressants: may enhance sedation or dizziness. - Psychiatric symptoms: monitor for mood changes, depression, or suicidal ideation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenytoin: may lower levetiracetam levels, decreasing seizure control. - Phenobarbital: can decrease levetiracetam exposure, risking breakthrough seizures.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression and impair coordination. - Other antiepileptics: combined use may require dose adjustments to maintain efficacy. - Renal excretion inhibitors: monitor renal function as they may affect levetiracetam clearance.